Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Arena Pharmaceuticals Inc.
Headquarters: San Diego, CA, United States of America
Website: N/A
Year Founded: 1997
Status: Acquired
BioCentury | Feb 25, 2025
Management Tracks
After leaving FDA, Cavazzoni joins Pfizer as CMO
Plus: CFO hires at Nuclera, Crinetics, Terns and updates from Xeris, Inhibikase and Climb Bio
BioCentury | Oct 15, 2024
Deals
Three new partnerships that could be worth over $1B
Deals report: Astellas-AviadoBio in CNS gene therapy deal, Merck-Mestag to identify inflammatory targets, Eli Lilly-KeyBioscience tackling obesity
BioCentury | Oct 14, 2024
Deals
Lundbeck bolts on Longboard, gains anticonvulsive in $2.6B deal
Danish pharma eyeing growth beyond loss of exclusivity for Rexulti, aiming for broad label in rare epilepsies
BioCentury | Oct 3, 2024
Finance
Kurma investing new fund; Kailera advancing obesity assets with $400M
BioCentury’s latest Venture Report also features news about LoQus23, Aktis, Resolution, Triveni, Flagship and more
BioCentury | Aug 20, 2024
Management Tracks
Toraishi steps down from Rakuten Medical as co-CEO
Plus: SalioGen hired Kalliopi Stasi as CMO and updates from PepGen, Cidara and Bio-Rad
BioCentury | Jan 10, 2024
Management Tracks
Mark Alles at the helm at Torl
Plus: new CSO at Nutcracker, and updates from
BioCentury | Oct 14, 2023
Finance
Oct. 13 Quick Takes: Pfizer trims guidance, cutting costs by $3.5B due to COVID product sales
Plus: FDA approves Pfizer’s ulcerative colitis therapy from Arena deal and updates from Lilly, Novo, Harmony and more
BioCentury | Sep 29, 2023
Data Byte
Thirteen PDUFA dates coming up in October
Highlights include decisions on Pfizer’s ulcerative colitis candidate etrasimod and Alnylam’s Onpattro for ATTR-CM
BioCentury | Sep 13, 2023
Management Tracks
CEO Nick Leschly shifting to chair as 2seventy bio restructures
Plus: CFO Galá promoted at Jazz, and updates from Geron, Mirum, ReNAgade,
BioCentury | Sep 1, 2023
Finance
Tier-jumpers: Building the road to sustainable biotechs. Back to School 2023
How companies can build value and climb market cap tiers to reach the top
Items per page:
1 - 10 of 510